Cited 0 times in
Phase II study of cisplatin with irinotecan as induction chemotherapy followed by chemoradiotherapy for unresectable stage III non-small cell lung cancer
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.